News

Alert Systems are Enhancing Response Efforts After Recent Calamities

HINESVILLE, Ga., Oct. 4, 2024 /PRNewswire/ -- Hospitals have been activating emergency internet alerts all over the Southeastern United States…

1 year ago

Career on Purpose (Episode 1): Merck’s Skills-First Program

NORTHAMPTON, MA / ACCESSWIRE / October 4, 2024 / Episode 1 of Career On Purpose, a new podcast series from…

1 year ago

Justera Health Announces Debt Settlement Transaction

. TORONTO, ON / ACCESSWIRE / October 4, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ( " Justera "or the"…

1 year ago

Aero Pump and Resyca Partner to Launch Ultra Soft Nasal Pump Spray, Targeting Precise Nasal Drug Delivery Applications

Now available for licensing, Ultra Soft Nasal Pump Spray leverages innovative spray nozzle chip technology for superior nasal cavity coverage…

1 year ago

HTL-Strefa Responds to Growing Calls for Affordable Healthcare With Cost-Effective Diabetes Solutions

Amidst recent news on healthcare pricing, HTL-Strefa, part of the MTD Group, reinforces its commitment to delivering innovative, high-quality pen…

1 year ago

Better Together: Nasser Orthodontics Will Merge With Cosse & Silmon Orthodontics on October 1, 2024

SHREVEPORT, LA / ACCESSWIRE / October 4, 2024 / Orthodontic patients in Louisiana will soon have a new reason to…

1 year ago

Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs

PRINCETON, NJ, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage…

1 year ago

CytoDyn Engages Syneos Health as CRO For Its Phase II Oncology Trial

VANCOUVER, Washington, Oct. 04, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab,…

1 year ago

Shriners Hospitals for Children Canada Hosts 36th Canada Shrine Bowl

Celebrating 100 years of caring for childrenMONTREAL, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The 36th edition of the Canada Shrine…

1 year ago

Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent Glioblastoma

October 4, 2024 Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent…

1 year ago